# Gulf War Illness Inflammation Reduction Trial

> **NCT02506192** · PHASE2 · COMPLETED · sponsor: **Minneapolis Veterans Affairs Medical Center** · enrollment: 83 (actual)

## Conditions studied

- Chronic Inflammation
- Chronic Pain
- Fatigue
- Cognitive Impairment

## Interventions

- **DRUG:** Modified-Release Prednisone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02506192
- **Lead sponsor:** Minneapolis Veterans Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2023-10-19
- **Final completion:** 2023-10-19
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2024-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02506192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02506192, "Gulf War Illness Inflammation Reduction Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02506192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*